ENTA - Enanta Pharma GAAP EPS of -$1.63 misses by $0.20 revenue of $18.72M misses by $1.95M May, 09 2022 04:06 PM Enanta Pharmaceuticals Inc. Enanta Pharma press release (NASDAQ:ENTA): Q2 GAAP EPS of -$1.63 misses by $0.20. Revenue of $18.72M (-7.0% Y/Y) misses by $1.95M. For further details see: Enanta Pharma GAAP EPS of -$1.63 misses by $0.20, revenue of $18.72M misses by $1.95M